SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PHP Healthcare

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Mac who wrote (5)12/9/1997 4:13:00 PM
From: Pierpont  Read Replies (1) of 136
 
The news today about Charles Robbins $10 million bid for the government business side of PPH operations is quite intriguing even though his offer seems to be summarily rejected as being too low. If this is merely the negotiation dance prior to taking this part of the company's business off the books, it should be enthusiastically applauded by Wall Street analysts who look askance at this lower margin pedestrian side of the business, and would accord a higher valuation to cleaner and leaner ( ie. no government biz ) looking company.
Additionally, Salomon Smith Barney, the co.'s underwriters of the convertible debenture offering in 1995 (?) has a/o one week ago bumped up their rating to Buy from neutral, apparently on improving margin outlook at both PPH core businesses and the newly acquired HIP NJ,
plus don't forget, there's more to come when they get HIP NY's business, too. The estimates of .86 for fiscal year 98 ( ending April )
look increasingly solid, if not conservative.
The increased activity augurs well for a solid move out a range, where it has been mirred for a good three quarters. Good luck on
this one !
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext